Domů › Crohnova choroba › Florida › Orlando
Klinické studie Crohnova choroba v Orlando, FL
17 studií pro Crohnova choroba hledá účastníky v lokalitách v Orlando a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Probíhá náborFáze 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Probíhá náborFáze 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · Vzdálenost 16 mi
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Probíhá náborFáze 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · Vzdálenost 16 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Probíhá náborFáze 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · Vzdálenost 24 mi
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Probíhá náborFáze 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · Vzdálenost 16 mi
- a dalších 1
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · Vzdálenost 16 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · Vzdálenost 16 mi
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Probíhá náborFáze 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · Vzdálenost 16 mi
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Probíhá nábor
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Probíhá náborObservační studie
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Probíhá náborFáze 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Probíhá náborFáze 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Probíhá náborFáze 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · Vzdálenost 16 mi
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Probíhá náborFáze 2
- Mirador Therapeutics Selected Site, Orlando
Studie Crohnova choroba v jiných městech
- New York City, NY35 studií
- Cleveland, OH19 studií
- St. Louis, MO19 studií
- Boston, MA19 studií
- Miami, FL19 studií
- Houston, TX17 studií
- Atlanta, GA17 studií
- Tyler, TX16 studií
- San Diego, CA15 studií
- San Antonio, TX15 studií
- Los Angeles, CA15 studií
- Philadelphia, PA13 studií
Další studie v Orlando
- Nemalobuněčný plicní karcinom44 studií
- Obesity31 studií
- Metastatický karcinom29 studií
- Nadváha27 studií
- Alzheimerova choroba25 studií
- Diabetes mellitus 2. typu24 studií
- Rakovina (všechny typy)24 studií
- Rakovina prsu23 studií
- Rakovina vaječníků22 studií
- Ulcerózní kolitida22 studií
- Rakovina plic21 studií
- Kolorektální karcinom19 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.